885 Cambie Street
Vancouver, BC V6B 0R6
|Mr. Stephen Van Deventer||Chairman & CEO||90,86k||N/A||1969|
|Dr. Makarand Jawadekar Ph.D.||Chief Science Officer, Pres & Director||55,45k||N/A||1951|
|Ms. Shabira Rajan CPA, CGA||CFO & Controller||60,56k||N/A||1956|
|Dr. Harendra Parekh Ph.D., BSc., Hons I, MRPharmS||Chief Research Officer||N/A||N/A||N/A|
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.
PreveCeutical Medical Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.